Biweekly Folfox4 and Folfiri in patients with advanced colorectal cancer (ACC)

被引：0
|
作者：
Infusino, Stefania [1 ]
Gadaleta-Caldarola, Gennaro [1 ]
Rea, Antonio [1 ]
Filice, Aldo [1 ]
Manfredi, Caterina [1 ]
Mastroianni, Candida Maria [1 ]
Sandomenico, Claudia [1 ]
Palazzo, Salvatore [1 ]
机构：
[1] Hosp Santa Maria, Div Med Oncol, Cosenza, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [1] Biweekly alternating FOLFOX and FOLFIRI in patients with previously untreated, advanced colorectal cancer (ACC): Updated results.
    Fernandez-Martos, C
    Aparicio, J
    Vicent, JM
    Maestu, I
    Llorca, C
    Busquier, I
    Campos, JM
    Asensio, D
    Romero, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 260S - 260S
  • [2] PHASE II TRIAL OF BIWEEKLY ALTERNATING FOLFOX AND FOLFIRI REGIMEN AS FIRST-LINE TREATMENT IN ADVANCED COLORECTAL CANCER (ACC)
    Bernardo, G.
    Palumbo, R.
    Bernardo, A.
    Villani, G.
    Poggi, G.
    Frascaroli, M.
    Jedrychowska, I.
    Delmonte, A.
    Teragni, C.
    Strada, M. R.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 59 - 59
  • [3] UFT MAINTAINANCE THERAPY IN PATIENTS (PTS) WITH ADVANCED COLORECTAL CANCER (ACC) RESPONSIVE TO FOLFOX4: PRELIMINARY RESULTS
    Brugnatelli, S.
    Scalamogna, R.
    Tronconi, M. C.
    Tinelli, C.
    Girino, M.
    Gattoni, E.
    Giordano, M.
    Luchena, G.
    Riccardi, A.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 63 - 63
  • [4] FOLFOX4 in advanced colorectal cancer: A monoinstitutional experience
    Boscolo, Giorgia
    Pasetto, Lara Maria
    Jirillo, Antonio
    Monfardini, Silvio
    [J]. TUMORI, 2006, 92 (03) : 193 - 196
  • [5] Adherence to the FOLFOX4 regimen in colorectal cancer patients
    Gonzalez, J.
    Gonzalez-Navarro, M.
    Albert-Mari, A.
    Lopez-Montenegro, M.
    Romero-Crespo, I.
    Jimenez-Torres, N. V.
    [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (06): : 1018 - 1018
  • [6] UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen
    Scalamogna, R.
    Brugnatelli, S.
    Tinelli, C.
    Sagrada, P.
    Gattoni, E.
    Tronconi, M. C.
    Riccardi, A.
    Luchena, G.
    Corazza, G. R.
    [J]. ONCOLOGY, 2007, 72 (5-6) : 267 - 273
  • [7] LONG-TERM BEVACIZUMAB TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CANCER WHO ARE RECEIVING FOLFOX4 AND FOLFIRI CHEMOTHERAPY
    Davidenko, Irina
    Kazantseva, Margarita
    Potemin, Sergey
    Elizbaryan, Karina
    Mamaeva, Elena
    Burdik, Oksana
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 98 - 98
  • [8] Pharmacogenetic analysis of clinical outcomes in advanced colorectal cancer patients treated with FOLFOX4 regimen
    Dong, Ningning
    Zhang, Shutian
    Wang, Mingyu
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 674 - 674
  • [9] Hematologic Toxicities in Colorectal Cancer Patients who Received FOLFOX4
    Dehghani, Mehdi
    Hafezi, Nematollah
    Vojdani, Reza
    Ramzi, Mani
    Karimi, Mojtaba
    Nourani, Habib
    Zakerinia, Maryam
    Bahador, Zahra
    [J]. MIDDLE EAST JOURNAL OF CANCER, 2015, 6 (03) : 171 - 177
  • [10] Economic evaluation of FOLFOX4 versus FOLFOX7 with oxaliplatin stop-and-go in advanced colorectal cancer patients
    Tilleul, P.
    Jasso Mosqueda, G.
    Trancart, A.
    Joly, A. C.
    Tournigand, C.
    Maindrault-Goebel, F.
    Le Pen, C.
    De Gramont, A.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A285 - A285
12345